Wall Street Experts
ver. ZuMIgo(08/25)
X4 Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 4
EBIT TTM (mln): -135
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
4 |
0 |
3 |
0 |
0 |
0 |
3 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
inf% |
-100.0% |
inf% |
-100.0% |
0.0% |
0.0% |
inf% |
Marża brutto |
0.0% |
0.0% |
0.0% |
100.0% |
-inf% |
100.0% |
-inf% |
-inf% |
-inf% |
68.8% |
EBIT (mln) |
-15 |
-24 |
-36 |
-46 |
-52 |
-60 |
-85 |
-88 |
-108 |
-36 |
EBIT Δ r/r |
0.0% |
64.2% |
48.4% |
27.0% |
12.7% |
15.8% |
42.1% |
2.9% |
22.8% |
-66.1% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-1311.0% |
0.0% |
-1995.8% |
0.0% |
0.0% |
0.0% |
-1423.6% |
Koszty finansowe (mln) |
0 |
3 |
2 |
1 |
2 |
3 |
4 |
4 |
6 |
9 |
EBITDA (mln) |
-12 |
-22 |
-32 |
-42 |
-44 |
-60 |
-85 |
-89 |
-106 |
-28 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-1195.1% |
0.0% |
-1995.8% |
0.0% |
0.0% |
0.0% |
-1078.5% |
Podatek (mln) |
0 |
3 |
2 |
4 |
4 |
0 |
0 |
0 |
0 |
0 |
Zysk Netto (mln) |
-13 |
-23 |
-34 |
-43 |
-57 |
-62 |
-89 |
-94 |
-101 |
-37 |
Zysk netto Δ r/r |
0.0% |
73.8% |
47.5% |
27.0% |
31.6% |
9.8% |
42.8% |
5.8% |
7.8% |
-63.0% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-1229.2% |
0.0% |
-2071.0% |
0.0% |
0.0% |
0.0% |
-1464.6% |
EPS |
-14.24 |
-24.76 |
-98.58 |
-93.73 |
-4.91 |
-3.09 |
-3.44 |
-1.48 |
-0.57 |
-0.19 |
EPS (rozwodnione) |
-14.24 |
-24.76 |
-98.58 |
-93.73 |
-4.91 |
-3.09 |
-3.44 |
-1.48 |
-0.57 |
-0.19 |
Ilośc akcji (mln) |
1 |
1 |
0 |
0 |
12 |
20 |
26 |
64 |
178 |
201 |
Ważona ilośc akcji (mln) |
1 |
1 |
0 |
0 |
12 |
20 |
26 |
64 |
178 |
201 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |